Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Prof. René-Jean Bensadoun
About This Webinar
(24, 25) Results of SafePBM trial: Feasibility, safety and efficacy of CareMin650, a new PBM device, for the prevention and treatment of mucositis and dermatitis in cancer patients
Who can view: People who attended or registered for the webinar only
Webinar Price: Free
Featured Presenters
MD MSc HRD, President WALT 2021
Prof. Bensadoun is Professor in Radiation Oncology, and Chairman at the Centre de Haute Energie in Nice, France. He was previously Full Professor and Chairman at the Department of Radiation Oncology, University Hospital of Poitiers in France. His fields of interest are Radiation Oncology, Head and Neck Cancer, Supportive Care in Cancer, Photobiomodulation, New techniques in Radiation Oncology, and Cancer-treatment toxicity. He is WALT Vice-President (2018); was past-Scientific Secretary for WALT
(2015-2017); SFCCF Deputy General Secretary; and Member of APPAC, EMLA, LED Academy. He’s also a Board Member of GORTEC (H & N Cancer French Groups), AFSOS, ANSM Radiation Oncology Expert, Deputy Associate Editor of the JSCC, Member of ESMO Toxicity Working Group and the MASCC-ISOO Mucositis Board and Oral Care Board. He’s the author of more than 190 peer reviewed papers.
(2015-2017); SFCCF Deputy General Secretary; and Member of APPAC, EMLA, LED Academy. He’s also a Board Member of GORTEC (H & N Cancer French Groups), AFSOS, ANSM Radiation Oncology Expert, Deputy Associate Editor of the JSCC, Member of ESMO Toxicity Working Group and the MASCC-ISOO Mucositis Board and Oral Care Board. He’s the author of more than 190 peer reviewed papers.
Conversation
Attended
(73)
Recommended